Impact of Flaxseed Lignan (Brevail) on Polycystic Ovarian Syndrome
Interventional
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Primary outcomes to assess are the changes of testosterone levels and hirsutism.
up to 6 months
No
Sam Kim, MD
Principal Investigator
The University of Kansas Medical Center
United States: Institutional Review Board
12459
NCT01396369
June 2011
June 2013
Name | Location |
---|---|
The University of Kansas Medical Center | Kansas City, Kansas 66160 |